Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 5

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 15
Chunk 5
---
 10.1
     
    11/08/2022

    10.27+
     
    Amendment No. 4 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated January 30, 2023
     
    10-Q

    10.1
     
    05/08/2023

    10.28+
     
    Amendment No. 5 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated September 27, 2023
     
    10-Q

    10.1
     
    11/01/2023

    10.29+
     
    Amendment No. 6 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated December 30, 2023
     
    10-K

    10.29
     
    03/28/2024

    10.30+
     
    Amendment No. 7 to Commercial Manufacturing Services Agreement between Atara Biotherapeutics, Inc. and Charles River Laboratories, Inc. dated January 31, 2024
     
    10-K

    10.30
     
    03/28/2024

    10.31+
     
    Amendment No. 8 to Commercial Manufacturing Services Agreement between Atara Biotheraputics, In. and Charles River Laboratories, Inc. dated March 31, 2024
     
    10-Q

    10.1
     
    05/09/2024

    10.32+
     
    Amendment No. 9 to Commercial Manufacturing Services Agreement between Atara Biotheraputics, In. and Charles River Laboratories, Inc. dated April 30, 2024
     
    10-Q

    10.1
     
    08/12/2024

136

    Exhibit

    Incorporated by Reference
     
    Filed

    Number
     
    Exhibit Description
     
    Form

    Exhibit
     
    Filing Date
     
    Herewith

    10.33+
     
    Amendment No. 10 to Commercial Manufacturing Services Agreement between Atara Biotheraputics, In. and Charles River Laboratories, Inc. dated May